Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

MYGN

Myriad Genetics Inc

May 14 • 04:00PM ET

3.62

-0.11 -2.95 %

Healthcare • Diagnostics & Research • USA • Small • NASD

Peers: FLGT PSNL NEO CDNA NTRA

| Held by: VTI XBI IWM VXF IWN IBB FESM VTWO FNDA SCHA

Index	RUT	P/E	-	EPS (ttm)	-4.32	Insider Own	6.77%	Shs Outstand	94.40M	Perf Week	-11.49%
Market Cap	341.90M	Forward P/E	21.81	EPS next Y	0.17	Insider Trans	2.44%	Shs Float	88.05M	Perf Month	-30.25%
Enterprise Value	429.00M	PEG	0.32	EPS next Q	-0.05	Inst Own	90.41%	Short Float	8.95%	Perf Quarter	-20.09%
Income	-399.90M	P/S	0.41	EPS this Y	3.70%	Inst Trans	-5.90%	Short Ratio	4.15	Perf Half Y	-45.81%
Sales	829.00M	P/B	1.01	EPS next Y	166.79%	ROA	-47.61%	Short Interest	7.88M	Perf YTD	-41.14%
Book/sh	3.57	P/C	2.75	EPS next 5Y	68.24%	ROE	-76.73%	52W High	8.59 -57.86%	Perf Year	-5.73%
Cash/sh	1.32	P/FCF	-	EPS past 3/5Y	-41.67% -8.03%	ROIC	-73.81%	52W Low	3.73 -2.95%	Perf 3Y	-79.70%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	6.72% 5.24%	Gross Margin	66.14%	Volatility	6.66% 6.38%	Perf 5Y	-86.78%
Dividend TTM	-	EV/Sales	0.52	EPS Y/Y TTM	-286.80%	Oper. Margin	-7.73%	ATR (14)	0.32	Perf 10Y	-89.64%
Dividend Ex-Date	-	Quick Ratio	2.19	Sales Y/Y TTM	-0.28%	Profit Margin	-48.24%	RSI (14)	30.21	Recom	2.90
Dividend Gr. 3/5Y	- -	Current Ratio	2.40	EPS Q/Q	-32981.82%	SMA20	-21.18%	Beta	1.74	Target Price	6.38
Payout	-	Debt/Eq	0.63	Sales Q/Q	2.30%	SMA50	-22.54%	Rel Volume	0.88	Prev Close	3.73
Employees	2700	LT Debt/Eq	0.61	Earnings	May 05 AMC	SMA200	-39.95%	Avg Volume	1.90M	Price	3.62
IPO	Oct 06, 1995	Option/Short	Yes / Yes	EPS/Sales Surpr.	-32.35% -1.00%	Trades		Volume	1,697,477	Change	-2.95%

Date	Action	Analyst	Rating Change	Price Target Change
May-21-25	Downgrade	Scotiabank	Sector Outperform → Sector Perform	$6
May-08-25	Downgrade	Wolfe Research	Outperform → Peer Perform
May-07-25	Downgrade	Wells Fargo	Overweight → Equal Weight	$6
Apr-09-25	Downgrade	Guggenheim	Buy → Neutral
Mar-12-25	Upgrade	Piper Sandler	Neutral → Overweight	$11.50 → $12.50
Feb-12-25	Initiated	Craig Hallum	Buy	$29
Dec-10-24	Initiated	UBS	Neutral	$18
Dec-09-24	Downgrade	Leerink Partners	Outperform → Market Perform	$30 → $21
Sep-19-24	Initiated	Morgan Stanley	Equal-Weight	$32
Aug-28-24	Initiated	Wells Fargo	Overweight	$35
Jun-27-24	Initiated	Scotiabank	Sector Outperform	$29
Jun-03-24	Resumed	Jefferies	Underperform	$20
May-08-24	Upgrade	Leerink Partners	Market Perform → Outperform	$25 → $35
Dec-21-23	Resumed	Piper Sandler	Neutral	$23
Dec-19-23	Initiated	Wells Fargo	Equal Weight	$20
Dec-14-23	Initiated	Guggenheim	Buy	$23
Dec-13-23	Initiated	Wolfe Research	Outperform	$28
Jul-05-23	Resumed	JP Morgan	Underweight	$18
May-23-23	Upgrade	Goldman	Sell → Buy	$18 → $25
Jan-18-23	Upgrade	Raymond James	Mkt Perform → Outperform	$25

Show Previous Ratings

May-07-26 04:05PM	Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences (GlobeNewswire)
May-06-26 08:30AM	Myriad Genetics, Inc. Q1 2026 Earnings Call Summary (Moby) -18.29%
May-05-26 05:14PM	Myriad: Q1 Earnings Snapshot (Associated Press)
04:05PM	Myriad Genetics Reports First Quarter 2026 Financial Results; Reiterates 2026 Financial Guidance Reflecting Ongoing Progress in the Cancer Care Continuum Business (GlobeNewswire)
Apr-30-26 09:05AM	Myriad Genetics National Survey: 88% of Patients with Depression and/or Anxiety Would Feel More Confident with a Personalized Mental Health Care Plan (GlobeNewswire)
04:05PM	Loading…
Apr-28-26 04:05PM	Myriad Genetics to Release First Quarter 2026 Financial Results on May 5, 2026 (GlobeNewswire)
Apr-16-26 09:15AM	Myriad Genetics to Deliver Six Abstracts, Including Two Podiums, at AACR 2026 (GlobeNewswire)
Apr-14-26 09:15AM	Myriad Genetics Expands Access for MyChoice Test to Prostate Cancer Patients in Japan (GlobeNewswire) +6.97%
Apr-09-26 09:15AM	Myriad Genetics Underscores Commitment to Cancer Care Continuum with New Data Presentations at SGO Annual Meeting (GlobeNewswire) -6.92%
Mar-17-26 04:05PM	Myriad Genetics Receives FDA Approval of the MyChoice CDx Test as the Companion Diagnostic for Zejula (niraparib) for Patients with Ovarian Cancer (GlobeNewswire)
Mar-10-26 12:40PM	Myriad Genetics (MYGN) Shares Skyrocket, What You Need To Know (StockStory) +6.44%
Mar-06-26 06:39PM	Vertiv Holdings, Lumentum Holdings, Coherent, and EchoStar Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600 (PR Newswire) -6.60%
Mar-03-26 03:35PM	Myriad Genetics (MYGN) Stock Trades Up, Here Is Why (StockStory) +5.59%
Mar-02-26 04:05PM	Myriad Commercially Launches Precise MRD with Select Community Oncologists (GlobeNewswire) +8.68%
Feb-24-26 11:25AM	Why Myriad Genetics (MYGN) Stock Is Trading Up Today (StockStory)
09:00AM	Loading…
09:00AM	Six presented abstracts at ASCO-GU 2026 reinforce the clinical impact of Myriad's Precise MRD, Prolaris, and MyRisk tests (GlobeNewswire)
08:30AM	Myriad Genetics, Inc. Q4 2025 Earnings Call Summary (Moby)
07:45AM	MYGN Stock Up on Q4 Earnings and Revenue Beat, Gross Margin Down (Zacks)
12:02AM	Myriad Genetics Inc (MYGN) Q4 2025 Earnings Call Highlights: Surpassing Revenue Expectations ... (GuruFocus.com)
Feb-23-26 08:00PM	Here's What Key Metrics Tell Us About Myriad (MYGN) Q4 Earnings (Zacks)
07:25PM	Myriad Genetics (MYGN) Q4 Earnings and Revenues Surpass Estimates (Zacks)
06:18PM	Myriad Genetics Q4 Earnings Call Highlights (MarketBeat)
04:52PM	Myriad: Q4 Earnings Snapshot (Associated Press Finance)
04:21PM	Myriad Genetics's (NASDAQ:MYGN) Q4 CY2025 Sales Top Estimates, Stock Jumps 22% (StockStory)
04:05PM	Myriad Genetics Reports Fourth Quarter and Full-Year 2025 Financial Results; Reiterates 2026 Financial Guidance Reflecting Strengthened Execution (GlobeNewswire)
12:07PM	Exact Sciences Stockholders Approve Abbott Merger as Executive Pay Proposal Fails at Special Meeting (MarketBeat)
Feb-19-26 09:15AM	FirstGene Study Demonstrates High Analytical Sensitivity and Specificity for Each Component of the Test (GlobeNewswire)
Feb-18-26 09:15AM	Ahead of Myriad (MYGN) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics (Zacks)
Feb-16-26 04:15PM	Myriad Genetics to Release Fourth Quarter and Full Year 2025 Financial Results on February 23, 2026 (GlobeNewswire)
Feb-12-26 08:02PM	Zydus Lifesciences Ltd (BOM:532321) Q3 2026 Earnings Call Highlights: Strong Revenue Growth ... (GuruFocus.com) -6.60%
10:07PM	Loading…
Feb-10-26 10:07PM	Quest Diagnostics Q4 Earnings Call Highlights (MarketBeat)
Jan-27-26 08:50AM	Myriad Advances MRD Commercialization Timeline, Bolstered by New Study Data (GlobeNewswire)
Jan-21-26 11:36PM	2 Healthcare Stocks with Solid Fundamentals and 1 That Underwhelm (StockStory)
Jan-13-26 07:30AM	TEM's Collab for Oncology Patient Population Is Gaining Attention (Zacks) -5.63%
Jan-12-26 08:30AM	Myriad Genetics Announces Select Preliminary Fourth Quarter and Full Year 2025 Financial Results and Introduces Full Year 2026 Financial Guidance (GlobeNewswire)
Jan-05-26 04:15PM	Myriad Genetics to Present at 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire) +6.19%
Dec-30-25 08:06AM	Should Myriad Genetics Stock Stay in Your Portfolio Right Now? (Zacks)
Dec-22-25 03:01PM	Myriad Genetics (MYGN) Stock Trades Up, Here Is Why (StockStory)
Dec-09-25 02:16PM	Why Myriad Genetics (MYGN) Stock Is Up Today (StockStory)
09:00AM	Myriad Genetics to Present 8 Abstracts about MRD and Other Studies at 2025 San Antonio Breast Cancer Symposium (GlobeNewswire)
Dec-08-25 11:03PM	Myriad Genetics (MYGN): Buy, Sell, or Hold Post Q3 Earnings? (StockStory)
Dec-04-25 11:30AM	Why Is Exelixis (EXEL) Up 9% Since Last Earnings Report? (Zacks)
Dec-03-25 11:30AM	Why Is Myriad (MYGN) Up 8.7% Since Last Earnings Report? (Zacks)
Dec-02-25 11:34PM	1 Healthcare Stock with Promising Prospects and 2 We Question (StockStory)
Dec-01-25 12:36PM	Why Myriad Genetics (MYGN) Stock Is Trading Lower Today (StockStory) -7.47%
Nov-25-25 04:15PM	Clairity, Myriad Genetics, and MagView Launch the First Integrated AI and Genetic Risk Platform for Personalized Breast Health (GlobeNewswire)
Nov-24-25 07:00PM	Myriad Genetics, Neogen, ICU Medical, HCA Healthcare, and Universal Health Services Stocks Trade Up, What You Need To Know (StockStory)
Nov-19-25 12:45PM	Why Myriad Genetics (MYGN) Stock Is Up Today (StockStory)
Nov-18-25 10:36PM	Q3 Earnings Roundup: Myriad Genetics (NASDAQ:MYGN) And The Rest Of The Therapeutics Segment (StockStory)
Nov-17-25 08:55AM	How Did Tempus AI Power Its Move to Positive EBITDA in Q3? (Zacks)
Nov-11-25 09:00AM	Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences (GlobeNewswire)
Nov-10-25 08:30AM	Myriad Genetics Adds 15 Clinically Actionable Genes to MyRisk Hereditary Cancer Test to Support Evolving Clinical Needs (GlobeNewswire)
12:31AM	The Top 5 Analyst Questions From Myriad Genetics's Q3 Earnings Call (StockStory)
Nov-06-25 08:30AM	Myriad Genetics to Highlight Genetic Testing Advancements at 2025 National Society of Genetic Counselors Annual Conference (GlobeNewswire)
Nov-04-25 11:56AM	Why Myriad Genetics (MYGN) Stock Is Down Today (StockStory) -21.03%
08:46AM	MYGN Q3 Deep Dive: Oncology Growth and Product Launches Offset Market Headwinds (StockStory)
12:00AM	Myriad Genetics Inc (MYGN) Q3 2025 Earnings Call Highlights: Navigating Revenue Decline with ... (GuruFocus.com)
Nov-03-25 07:00PM	Myriad (MYGN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:40PM	Myriad Genetics (MYGN) Reports Break-Even Earnings for Q3 (Zacks)
05:27PM	Myriad Genetics's (NASDAQ:MYGN) Q3 Earnings Results: Revenue In Line With Expectations But Stock Drops (StockStory)
04:40PM	Myriad: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution (GlobeNewswire)
Nov-01-25 11:07PM	What To Expect From Myriad Genetics's (MYGN) Q3 Earnings (StockStory)
Oct-31-25 09:28AM	Earnings To Watch: Myriad Genetics Inc (MYGN) Reports Q3 2025 Result (GuruFocus.com)
09:05AM	New Post-Hoc Analysis Shows Patients Whose Clinicians Had Access to GeneSight Results for Depression Treatment Are More Likely to Feel Better Sooner (GlobeNewswire)
Oct-27-25 04:15PM	Myriad Genetics to Release Third Quarter 2025 Financial Results on November 3, 2025 (GlobeNewswire)
Oct-17-25 12:36AM	2 Unpopular Stocks That Deserve a Second Chance and 1 That Underwhelm (StockStory)
Oct-14-25 08:00AM	Myriad Genetics Adds F8, FXN Genes to Foresight Universal Plus Panel (GlobeNewswire)
Oct-10-25 03:51PM	Myriad Genetics, Omnicell, Globus Medical, Repligen, and Teleflex Stocks Trade Down, What You Need To Know (StockStory)
Oct-08-25 08:20AM	Hologic Expands Panther Fusion's Menu With Diagnostic Innovation (Zacks)
Oct-02-25 09:15AM	Illumina to Join Pharma Partners for CDx Development on KRAS Biomarker (Zacks)
Oct-01-25 11:31PM	A Look Back at Therapeutics Stocks' Q2 Earnings: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Pack (StockStory) +6.92%
Sep-23-25 08:01AM	Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy (PR Newswire)
Sep-17-25 12:34AM	3 Small-Cap Stocks That Concern Us (StockStory)
Sep-16-25 08:20AM	Is it a Prudent Move to Retain MYGN Stock in Your Portfolio Now? (Zacks)
Sep-08-25 08:14AM	MYGN Stock Might Gain on The Lancet Study Backing Precise MRD (Zacks)
Sep-05-25 10:56AM	MYGN's GeneSight Test Proven Superior to TAU: Stock to Gain? (Zacks)
12:39AM	3 Russell 2000 Stocks with Open Questions (StockStory)
Sep-04-25 07:00PM	Myriad Genetics Announces Precise MRD Clinical Data Published in The Lancet Oncology (GlobeNewswire)
Sep-03-25 04:30PM	New Meta-Analysis Demonstrates that Access to the GeneSight Test Can Significantly Improve Response and Remission Rates for Patients with Depression (GlobeNewswire)
Aug-27-25 04:05PM	Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences (GlobeNewswire)
Aug-20-25 02:00AM	ANGLE Announces Collaboration with Myriad Genetics (ACCESSWIRE)
Aug-18-25 08:30AM	Myriad Genetics Appoints Ben Wheeler Chief Financial Officer (GlobeNewswire)
12:36AM	3 Healthcare Stocks We're Skeptical Of (StockStory)
Aug-13-25 08:00AM	New Myriad Genetics Survey Uncovers Women Fear Screenings-But Feel Reassured by the Results (GlobeNewswire)
12:11AM	Myriad Genetics's Q2 Earnings Call: Our Top 5 Analyst Questions (StockStory)
12:10AM	MYGN Q2 Deep Dive: Oncology Strategy Shift and Product Execution Shape Guidance (StockStory)
Aug-12-25 10:00AM	RxPreferred Benefits Expands Executive Leadership Team with Strategic Appointment and Key Promotions (PR Newswire)
12:03AM	3 Reasons MYGN is Risky and 1 Stock to Buy Instead (StockStory)
Aug-11-25 07:45AM	TD Cowen Maintained a Hold Rating on Myriad Genetics (MYGN) (Insider Monkey)
Aug-06-25 04:57PM	CareDx Announces Appointment of Nathan Smith as Chief Financial Officer (Business Wire) +46.51% +7.58%
01:11PM	Why Is Myriad Genetics (MYGN) Stock Soaring Today (StockStory)
Aug-05-25 06:30PM	Compared to Estimates, Myriad (MYGN) Q2 Earnings: A Look at Key Metrics (Zacks)
05:55PM	Myriad Genetics (MYGN) Q2 Earnings and Revenues Surpass Estimates (Zacks)
04:52PM	Myriad: Q2 Earnings Snapshot (Associated Press Finance)
04:48PM	Myriad Genetics (NASDAQ:MYGN) Reports Strong Q2, Stock Jumps 30.6% (StockStory)
04:05PM	Myriad Genetics Reports Second Quarter 2025 Financial Results; Raises 2025 Revenue Guidance Following Positive Business Momentum (GlobeNewswire)
Aug-03-25 11:13PM	Earnings To Watch: Myriad Genetics (MYGN) Reports Q2 Results Tomorrow (StockStory)
Jul-31-25 08:30AM	Myriad Genetics Announces New $200 Million Credit Facility (GlobeNewswire) -5.19%
Jul-29-25 04:05PM	Myriad Genetics to Release Second Quarter 2025 Financial Results on August 5, 2025 (GlobeNewswire) -6.39%

Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic tests. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Bisaro Paul	Director	May 14 '26	Buy	3.69	7,500	27,638	97,441	May 14 05:16 PM
Raha Samraat S.	President and CEO	Mar 09 '26	Buy	5.00	40,000	199,844	493,104	Mar 09 07:03 PM
Phanstiel S. Louise	Director	Feb 26 '26	Buy	4.80	50,407	242,105	233,951	Feb 27 04:46 PM
Phanstiel S. Louise	Director	Feb 27 '26	Buy	4.66	48,000	223,728	281,951	Feb 27 04:46 PM
Phanstiel S. Louise	Director	Feb 25 '26	Buy	4.74	6,100	28,890	183,544	Feb 27 04:46 PM

Peers: ELAN IDXX PAHC PFE TEVA VTRS RDY AMPH PRGO OGN

| Held by: VTI VOO VO IVV SPY VOT VUG VIG XLV VTV

Index	S&P 500	P/E	12.50	EPS (ttm)	6.04	Insider Own	0.56%	Shs Outstand	420.35M	Perf Week	-13.55%
Market Cap	31.64B	Forward P/E	10.10	EPS next Y	7.47	Insider Trans	-0.35%	Shs Float	416.86M	Perf Month	-37.50%
Enterprise Value	38.94B	PEG	1.24	EPS next Q	1.87	Inst Own	101.21%	Short Float	3.55%	Perf Quarter	-39.92%
Income	2.64B	P/S	3.33	EPS this Y	8.34%	Inst Trans	4.25%	Short Ratio	2.89	Perf Half Y	-37.16%
Sales	9.51B	P/B	9.81	EPS next Y	7.58%	ROA	18.07%	Short Interest	14.80M	Perf YTD	-40.01%
Book/sh	7.69	P/C	16.30	EPS next 5Y	8.12%	ROE	67.01%	52W High	172.23 -56.17%	Perf Year	-51.28%
Cash/sh	4.63	P/FCF	14.81	EPS past 3/5Y	10.25% 11.96%	ROIC	21.19%	52W Low	74.29 1.60%	Perf 3Y	-58.89%
Dividend Est.	2.13 (2.82%)	EV/EBITDA	9.59	Sales past 3/5Y	5.42% 7.24%	Gross Margin	70.43%	Volatility	5.48% 3.44%	Perf 5Y	-56.19%
Dividend TTM	2.06 (2.73%)	EV/Sales	4.10	EPS Y/Y TTM	8.35%	Oper. Margin	37.57%	ATR (14)	4.46	Perf 10Y	62.71%
Dividend Ex-Date	Apr 20, 2026	Quick Ratio	1.91	Sales Y/Y TTM	2.40%	Profit Margin	27.79%	RSI (14)	14.10	Recom	1.77
Dividend Gr. 3/5Y	14.57% 19.02%	Current Ratio	3.15	EPS Q/Q	1.02%	SMA20	-28.16%	Beta	0.77	Target Price	129.07
Payout	33.71%	Debt/Eq	2.86	Sales Q/Q	1.89%	SMA50	-33.19%	Rel Volume	1.71	Prev Close	74.34
Employees	14500	LT Debt/Eq	2.86	Earnings	May 07 BMO	SMA200	-41.70%	Avg Volume	5.12M	Price	75.48
IPO	Feb 01, 2013	Option/Short	Yes / Yes	EPS/Sales Surpr.	-4.60% -1.71%	Trades		Volume	8,714,798	Change	1.53%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-15-26	Initiated	Citigroup	Buy	$145
Jan-22-26	Downgrade	Piper Sandler	Overweight → Neutral	$135
Dec-15-25	Downgrade	BofA Securities	Buy → Neutral	$135
Dec-09-25	Initiated	Barclays	Equal Weight	$136
Nov-21-25	Initiated	KeyBanc Capital Markets	Sector Weight
Jul-17-25	Downgrade	Leerink Partners	Outperform → Market Perform	$155
Jun-18-25	Downgrade	Stifel	Buy → Hold	$160
Dec-02-24	Initiated	Leerink Partners	Outperform	$215
Jul-25-24	Initiated	BTIG Research	Buy	$220
Jan-12-24	Reiterated	Stifel	Buy	$195 → $215
Dec-19-23	Resumed	Jefferies	Buy	$230
Dec-07-23	Initiated	Exane BNP Paribas	Outperform	$237
Sep-06-23	Initiated	HSBC Securities	Buy	$230
Jul-12-22	Initiated	Piper Sandler	Overweight	$205
Nov-18-21	Initiated	Morgan Stanley	Overweight	$40
Nov-18-21	Initiated	Morgan Stanley	Overweight	$264
Aug-05-21	Resumed	Credit Suisse	Outperform	$206
Jul-16-21	Downgrade	Raymond James	Outperform → Mkt Perform
Mar-08-21	Upgrade	Raymond James	Mkt Perform → Outperform	$166
Mar-08-21	Upgrade	BofA Securities	Neutral → Buy	$180

Show Previous Ratings

May-11-26 04:30PM	Zoetis Inc. stock underperforms Monday when compared to competitors (MarketWatch) -7.44%
May-07-26 08:45PM	Zoetis Inc. Q1 2026 Earnings Call Summary (Moby) -21.50% -5.13%
04:30PM	Zoetis Inc. stock underperforms Thursday when compared to competitors (MarketWatch)
12:09PM	Why Zoetis' Slashed 2026 Guidance Still Appears To Be A 'Heavy Lift' (Investor's Business Daily)
11:47AM	Zoetis Is Today's Worst S&P 500 Stock. Why the Quarter Is 'Worse Than It Seems.' (Barrons.com)
07:59AM	Loading…
07:59AM	Dow Jones makes flat start, Nasdaq climbs as Datadog and Fortinet soar (Proactive)
07:59AM	Dow Jones dips, Nasdaq climbs as Datadog and Fortinet soar (Proactive)
07:08AM	Zoetis: Q1 Earnings Snapshot (Associated Press)
07:00AM	Zoetis Announces First Quarter 2026 Results (Business Wire)
Apr-16-26 09:47AM	Qualcomm downgraded, Okta upgraded: Wall Street's top analyst calls (The Fly)
Apr-15-26 09:47AM	Cloudflare upgraded, SolarEdge downgraded: Wall Street's top analyst calls (The Fly)
Apr-02-26 08:30AM	Zoetis to Host Webcast and Conference Call on First Quarter 2026 Financial Results (Business Wire)
Mar-23-26 01:38PM	Pet Services Jump 5.1% as Vet Visits Fall for 16th Straight Quarter (GuruFocus.com)
Mar-16-26 04:19AM	Is IDEXX Laboratories Stock Outperforming the S&P 500? (Barchart)
Mar-14-26 02:49PM	Stablecoins becoming macro-relevant financial layer, BCA says (Investing.com)
08:30AM	Loading…
Mar-12-26 08:30AM	Zoetis to Participate in the KeyBanc Capital Markets Healthcare Forum (Business Wire)
Mar-06-26 09:40AM	Here's Why Zoetis (ZTS) is a Strong Value Stock (Zacks)
09:30AM	Jensen Quality Growth Equity Decided to Sell Its Stake in Zoetis (ZTS) (Insider Monkey)
07:54AM	Here Are Fridays Top Wall Street Analyst Research Calls: BorgWarner, CoreWeave, Intuit, Marvell Technology, Netflix, Okta, Regeneron Pharmaceuticals, Trade Desk, and More (24/7 Wall St.)
Mar-05-26 08:30AM	Zoetis to Participate in Upcoming Investor Conferences (Business Wire)
Mar-02-26 07:00AM	Zoetis to Acquire Animal Genomics Business from Neogen, Accelerating Precision Animal Health Innovation (Business Wire)
04:07AM	Zacks.com featured highlights include Ross Stores, Globe Life, Banco Bilbao, Zoetis and TE Connectivity (Zacks)
Mar-01-26 05:06AM	Phibro Animal Health Raises Guidance at BofA Conference as Zoetis MFA Integration Advances (MarketBeat)
Feb-27-26 04:51PM	Top Stock Reports for NVIDIA, Microsoft & JPMorgan (Zacks)
11:00AM	Buy 5 Stocks With High ROE as Markets Dance Whimsically to the AI Tune (Zacks)
05:29AM	Zoetis Stock: Is ZTS Underperforming the Healthcare Sector? (Barchart)
Feb-26-26 11:03PM	2 Reasons to Like ZTS (and 1 Not So Much) (StockStory)
Feb-24-26 04:22PM	Elanco Animal Health Q4 Earnings Call Highlights (MarketBeat)
09:50AM	Why Zoetis (ZTS) is a Top Momentum Stock for the Long-Term (Zacks)
08:30AM	Zoetis to Participate in the Bank of America Securities 2026 Animal Health Summit (Business Wire)
10:57AM	Loading…
Feb-23-26 10:57AM	Barclays Remains a Hold on Zoetis Inc. (ZTS) (Insider Monkey)
Feb-19-26 12:38AM	The Top 5 Analyst Questions From Zoetis's Q4 Earnings Call (StockStory)
Feb-18-26 10:05AM	Zoetis (ZTS) Falls Following Q3 Disappointment and Librela Demand Weakness (Insider Monkey)
09:40AM	Why Zoetis (ZTS) is a Top Value Stock for the Long-Term (Zacks)
04:01AM	Bank of America Cites Zoetis Inc.'s (ZTS) Strong Q4 Performance and Fiscal 2026 Outlook (Insider Monkey)
Feb-13-26 04:57PM	Analyst Report: Zoetis Inc. (Morningstar Research)
07:13AM	Zoetis Q4 Earnings Call Highlights (MarketBeat)
12:35AM	ZTS Q4 Deep Dive: Product Innovation and Competitive Pressures Shape Outlook (StockStory)
Feb-12-26 04:15PM	Zoetis Stock Is In The Doghouse Despite Its Quarterly Beat; Here's Why (Investor's Business Daily)
04:05PM	Zoetis Inc (ZTS) Q4 2025 Earnings Call Highlights: Strong Full-Year Growth Amid Competitive ... (GuruFocus.com)
01:24PM	Analysts Question Zoetis' Pathway To Growth As Key Segments Slide (Benzinga)
12:32PM	Zoetis Inc. Q4 2025 Earnings Call Summary (Moby)
10:30AM	Zoetis Stock Gains After Q4 Earnings & Revenues Beat Estimates (Zacks)
09:30AM	Zoetis (ZTS) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
08:45AM	Zoetis Jumps After Pet-Health Outlet Barks Up A Fourth-Quarter Beat (Investor's Business Daily)
08:10AM	Zoetis (ZTS) Beats Q4 Earnings and Revenue Estimates (Zacks)
07:46AM	Zoetis shares jump after beating Q4 expectations (Investing.com)
07:38AM	Zoetis's (NYSE:ZTS) Q4 CY2025 Sales Top Estimates (StockStory)
07:05AM	Zoetis: Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	Zoetis Reports Fourth Quarter and Full Year 2025 Results (Business Wire)
05:36AM	Applied Materials headlines earnings slate (MarketWatch)
04:50AM	Stock Market Today: Dow, S&P 500 and Nasdaq point higher as tech finds its footing; Treasurys steady; precious metals dip. (MarketWatch)
Feb-10-26 10:09PM	Zoetis (ZTS) Reports Q4: Everything You Need To Know Ahead Of Earnings (StockStory)
10:00AM	Analysts Estimate USANA Health Sciences (USNA) to Report a Decline in Earnings: What to Look Out for (Zacks)
Feb-09-26 11:30AM	Robinhood, AppLovin, Rivian and More Stocks With Earnings This Week (Benzinga)
10:22AM	Zoetis Gears Up to Report Q4 Earnings: Here's What to Expect (Zacks)
09:15AM	Curious about Zoetis (ZTS) Q4 Performance? Explore Wall Street Estimates for Key Metrics (Zacks)
08:55AM	How to Find Strong Medical Stocks Slated for Positive Earnings Surprises (Zacks)
Feb-06-26 08:57AM	Pelican Bay Capital Management Bets on Zoetis (ZTS) to Capitalize on Expanding Pet Care Market (Insider Monkey)
Feb-05-26 04:15PM	Zoetis Declares Second Quarter 2026 Dividend (Business Wire)
12:22PM	Do Wall Street Analysts Like Zoetis Stock? (Barchart)
10:00AM	Zoetis (ZTS) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
09:50AM	Here's Why Zoetis (ZTS) is a Strong Momentum Stock (Zacks)
Feb-04-26 02:18PM	Zoetis Inc. (ZTS): A Bull Case Theory (Insider Monkey)
Feb-03-26 06:15PM	Zoetis (ZTS) Registers a Bigger Fall Than the Market: Important Facts to Note (Zacks)
11:40AM	SGIOY vs. ZTS: Which Stock Is the Better Value Option? (Zacks)
10:00AM	5 Drug/Biotech Stocks Likely to Outperform Q4 Earnings Estimates (Zacks)
09:45AM	Here's Why Zoetis (ZTS) is a Strong Growth Stock (Zacks)
08:14AM	Zoetis (ZTS) Traded Lower Due to Reduced 2026 Outlook (Insider Monkey)
Jan-31-26 12:35PM	Zoetis Inc. (ZTS) Sees Mixed Analyst Sentiment as Targets Are Trimmed (Insider Monkey)
Jan-30-26 09:40AM	Zoetis (ZTS) is a Top-Ranked Value Stock: Should You Buy? (Zacks)
Jan-28-26 06:15PM	Zoetis (ZTS) Dips More Than Broader Market: What You Should Know (Zacks)
Jan-27-26 04:04PM	Gold and Silver Arent the Only Hot Commodities. Agricultural Stocks to Consider. (Barrons.com)
08:55AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
Jan-26-26 04:27PM	Piper Sandler Flags Near-Term Uncertainty for Zoetis (ZTS) Despite Long-Term Appeal (Insider Monkey)
Jan-23-26 09:41AM	Alphabet upgraded, Micron initiated: Wall Streets top analyst calls (TipRanks)
Jan-22-26 01:25PM	2 Healthcare Stocks Poised for a Comeback in 2026 (Motley Fool)
12:20PM	This Could Be One of the Best Healthcare Stock Buying Opportunities I've Seen in Years (Motley Fool)
12:10PM	Will Zoetis (ZTS) Beat Estimates Again in Its Next Earnings Report? (Zacks)
09:37AM	Alphabet upgraded, Micron initiated: Wall Street's top analyst calls (The Fly)
08:55AM	These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar (Zacks)
Jan-20-26 10:35PM	Q3 Earnings Roundup: Zoetis (NYSE:ZTS) And The Rest Of The Branded Pharmaceuticals Segment (StockStory)
Jan-16-26 09:25AM	What to Expect From Zoetis' Next Quarterly Earnings Report (Barchart)
Jan-12-26 06:15PM	Zoetis (ZTS) Stock Dips While Market Gains: Key Facts (Zacks)
04:52PM	Zoetis CEO on Animal Health, Vaccines and Beef Prices (Bloomberg)
09:22AM	Zoetis (ZTS): Harnessing Growth with Minimum Rivalry (Insider Monkey)
Jan-07-26 02:11PM	Trade Tracker: Stephanie Link sells Eaton and buys more Zoetis, Natera (CNBC TV)
11:40AM	UTHR vs. ZTS: Which Stock Is the Better Value Option? (Zacks)
Dec-31-25 09:15AM	2 Beaten-Down Stocks That Could Bounce Back in 2026 (Motley Fool)
Dec-30-25 05:52PM	BofA Downgrades Zoetis (ZTS) to Neutral, Cuts Price Target (Insider Monkey)
08:30AM	Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2025 Financial Results (Business Wire)
Dec-28-25 02:17AM	Zoetis (ZTS) Positioned Within Morgan Stanley's 2026 Healthcare Playbook (Insider Monkey)
Dec-23-25 04:16PM	Trade Tracker: Stephanie Link buys mores Zoetis (CNBC TV)
Dec-22-25 06:15PM	Zoetis (ZTS) Outperforms Broader Market: What You Need to Know (Zacks)
Dec-19-25 03:34PM	More US Beef Plants May Close as Cattle Herds Keep Shrinking (Bloomberg)
07:45AM	Got $5,000? These 3 Growth Stocks Are Trading Near Their Lows. (Motley Fool)
Dec-18-25 08:30AM	Zoetis to Participate in the 44th Annual J.P. Morgan Healthcare Conference (Business Wire)
Dec-17-25 05:00PM	These 2 Healthcare Stocks Just Declared Dividend Raises (Motley Fool)
09:01AM	4 Stocks That Declared Dividend Hikes Amid Ongoing Economic Uncertainty (Zacks)
Dec-16-25 01:15AM	Zoetis Announces Pricing of $1.75 Billion Convertible Senior Notes Offering (Business Wire)

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. It operates through the United States and International geographical segments. The company was founded in 1952 and is headquartered in Parsippany, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
DAMELIO FRANK A	Director	May 13 '26	Buy	75.39	6,650	501,344	21,458	May 13 04:35 PM
Bisaro Paul	Director	May 13 '26	Buy	75.88	2,000	151,750	27,862	May 13 04:35 PM
MCCALLISTER MICHAEL B	Director	May 11 '26	Buy	77.76	3,000	233,273	24,524	May 12 07:26 PM
PECK KRISTIN C	Chief Executive Officer	Feb 17 '26	Option Exercise	41.83	20,000	836,600	121,337	Feb 17 04:22 PM
PECK KRISTIN C	Chief Executive Officer	Feb 17 '26	Sale	127.05	20,000	2,540,964	101,337	Feb 17 04:22 PM
Polzer Robert J	Officer	Feb 17 '26	Proposed Sale	127.34	2,346	298,742		Feb 17 04:14 PM
PECK KRISTIN C	Officer	Feb 17 '26	Proposed Sale	127.05	20,000	2,540,964		Feb 17 04:13 PM
Polzer Robert J	Officer	Feb 13 '26	Proposed Sale	129.09	3,662	472,728		Feb 13 04:26 PM
Lagano Roxanne	Executive Vice President	Jun 03 '25	Sale	170.00	652	110,840	15,129	Jun 04 04:31 PM
Lagano Roxanne	Officer	Jun 03 '25	Proposed Sale	170.00	652	110,840		Jun 03 04:22 PM

MYGN

Myriad Genetics Inc

ZTS

Zoetis Inc

Upgrade your Finviz experience